Jianwu Qin

A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer

Xiangqian Zheng, Zhengang Xu, Qinghai Ji et al. · Clinical Cancer Research · 2021 · 42 citations · Full text

Medicine, Oncology, Pharmacology +7

Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial

Yihebali Chi, Xiangqian Zheng, Yuan Zhang et al. · Clinical Cancer Research · 2023 · 37 citations · Full text

Medicine, Oncology, Pharmacology +11

Anlotinib treatment in locally advanced or metastatic medullary thyroid carcinoma: A multicenter, randomized, double-blind, placebo-controlled phase IIB trial.

Dapeng Li, Ping Tang, Minghua Ge et al. · Journal of Clinical Oncology · 2019 · 14 citations

Medicine, Oncology, Pharmacology +16

265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial

Y. Chi, Ming Gao, Y. Zhang et al. · Annals of Oncology · 2020 · 10 citations

Medicine, Endocrinology, Oncology +9